Sildenafil Citrate
Product Images NDC 42543-005

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 42543-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vensun Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

The packaging label for Sildenafil Tablets, USP, 20 mg, contains 1,000 film-coated tablets. The label indicates the product is manufactured for Vensun Pharmaceuticals, Inc. and by Rubicon Research Private Limited in India. Storage instructions, dosage notes, and a pharmacist dispensing notice are included. Two barcodes appear on the label.*

FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

Sildenafil Tablets USP 20 mg film-coated tablet label, manufactured for Vensun Pharmaceuticals, Inc. The label states each tablet contains sildenafil citrate equivalent to 20 mg sildenafil. It includes storage instructions (20°-25°C), dispensing information, and packaging size of 90 tablets. Barcodes and manufacturing details by Rubicon Research Private Limited, India, are also visible.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 06)

A stepwise line graph showing estimated cumulative mortality rate (%) over time (years) for three dose groups labeled High Dose, Medium Dose, and Low Dose. The graph includes number-at-risk tables above the x-axis for each dose group at various time points up to 5 years, illustrating increasing mortality rates with higher doses.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 07)

A forest plot showing fold changes and 90% confidence intervals for drug interactions affecting Sildenafil Citrate pharmacokinetics. It compares area under the curve (AUC) and maximum concentration (Cmax) of Sildenafil when coadministered with various interacting drugs such as Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir. Recommendations on dose adjustments or coadministration guidance are provided alongside each drug.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 08)

A chart illustrating fold change and 90% confidence intervals for the effect of various interacting drugs on the pharmacokinetics of Sildenafil Citrate. The horizontal axis shows change relative to the interacting drug alone, with a vertical line at 1. The chart lists multiple drugs on the vertical axis and shows fold changes in INR AUC, INR Cmax, BT, AUC, and Cmax values along with dosing recommendations, mostly indicating no dose adjustment except for ritonavir where coadministration is not recommended.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 09)

A line graph showing change from baseline in meters over a 12-week study, comparing placebo and Sildenafil Citrate dosages of 20mg, 40mg, and 80mg taken three times daily (TID). The y-axis measures change from baseline in meters, and the x-axis represents weeks 4, 8, and 12 of the study. Error bars indicate variability at each point.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 10)

A forest plot chart showing the placebo-corrected change in 6-minute walk distance (meters) with Sildenafil 20 mg TID, stratified by baseline walk distance, etiology, functional class, gender, age, mean PAP, and PVRI. It includes numerical data for placebo and Sildenafil groups and confidence intervals for each category.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 11)

A line graph comparing the percentage without a clinically worsening event over days from randomization between Sildenafil and Placebo groups. The x-axis represents days from randomization (0 to 112), and the y-axis shows the percentage without a clinically worsening event (0 to 100%). Sildenafil's data is depicted with a dashed line, and Placebo with a solid line, showing a higher percentage over time for Sildenafil.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 12)

A line plot showing the mean change from baseline with standard error bars for three Sildenafil citrate dosages (1 mg, 5 mg, and 20 mg TID) over a 12-week study period at Weeks 4, 8, and 12. The y-axis represents change from baseline in meters, and the x-axis represents the week of study.*

FDA Label Image

Structure Formula (Sildenafil Tablets Usp 20mg Structure)

Chemical structure of Sildenafil Citrate showing its complex arrangement of rings including pyrazolo and piperazine groups, with various functional groups such as ethoxy, sulfonamide, methyl, and carboxyl groups represented in a two-dimensional format.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.